Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Aussie Court Battle Reveals Progen Offered Pay For Avexa Merger Votes

This article was originally published in PharmAsia News

Executive Summary

Progen Pharmaceuticals of Australia apparently offered to pay shareholders for their votes in support of a merger with Avexa, according to information in a federal court case. At issue are conflicting schedules for shareholder meetings to decide on the Progen-Avexa merger. Progen scheduled a March 11 meeting of its shareholders to vote on the proposal, while Cytopia, an Avexa competitor, is in court seeking to delay the meeting until March 27, after it has had a chance to present its own resolution to oust Progen's board. According to court documents, Progen had offered to pay a broker a fee for all proxies that supported the merger. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts